Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
44.85 EUR | +3.94% | +3.94% | -20.39% |
04-25 | Formycon AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-18 | Formycon, Fresenius Kabi Sign Settlement Deal with Johnson & Johnson for Ustekinumab Biosimilar | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-20.39% | 821M | |
+23.37% | 47.02B | |
+49.45% | 41.86B | |
-0.94% | 41.76B | |
-5.86% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- FYB Stock
- News Formycon AG
- Formycon Raises EUR70 Million to Fund Biosimilar Candidates' Development